DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

Cytokinetics, Inc. (NASDAQ: CYTK)

6.39 0.30 (4.93%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CYTK $6.39 4.93%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.15
Previous Close $6.09
Daily Range $5.90 - $6.42
52-Week Range $3.05 - $8.61
Market Cap $247.4M
P/E Ratio -14.50
Dividend (Yield) $0.00 (0.0%)
Volume 448,357
Average Daily Volume 364,262
Current FY EPS -$1.31

Sector

Healthcare

Industry

Drug Makers

Cytokinetics, Inc. (CYTK) Description

A biopharmaceutical company, focused on developing small molecule therapeutics for the treatment of cardiovascular diseases and cancer. Website: http://www.cytokinetics.com/

News & Commentary

Why Cytokinetics Inc. Shares Soared Today

Cytokinetics Inc. shares jumped by over 10% earlier in the day after reporting financial results for 2015.

Cytokinetics' (CYTK) CEO Robert Blum on Q2 2015 Results - Earnings Call Transcript

New Strong Sell Stocks for July 24th - Tale of the Tape

Will Biogen (BIIB) Surprise in 2Q Despite Tecfidera Issues? - Analyst Blog

Will AbbVie (ABBV) Surprise on Earnings Again in Q2? - Analyst Blog

Cytokinetics Is Proof That Biotech Bargains Still Exist

Seeking Alpha's Biotech Weekly: Valeant Buys Again, Celgene-Receptos, And More

Cytokinetics Advances Tirasemtiv to Phase III, Shares Up - Analyst Blog

Cytokinetics (CYTK) Jumps: Stock Adds 6.8% in Session - Tale of the Tape

Mid-Day Market Update: Vince Holding Declines After CEO Resignation; Natural Health Trends Shares Su

Mid-Day Market Update: Vince Holding Declines After CEO Resignation; Natural Health Trends Shares Surge

Mid-Day Market Update: Vince Holding Declines After CEO Resignation; Natural Health Trends Shares Su

Mid-Day Market Update: Vince Holding Declines After CEO Resignation; Natural Health Trends Shares Surge

See More CYTK News...

CYTK's Top Competitors

CYTK $6.39 (4.93%)
Current stock: CYTK
AMGN $176.59 (2.85%)
Current stock: AMGN
GILD $117.86 (-0.03%)
Current stock: GILD
BIIB $318.78 (0.56%)
Current stock: BIIB